- Report
- October 2025
- 50 Pages
Global
From €2363EUR$2,650USD£2,058GBP
- Report
- September 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP
- Report
- August 2025
- 184 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- October 2025
- 50 Pages
Global
From €2363EUR$2,650USD£2,058GBP
Pentobarbital is a barbiturate drug used to treat a variety of conditions related to the central nervous system. It is used to treat seizures, insomnia, and anxiety, as well as to induce anesthesia and sedation. Pentobarbital is also used in veterinary medicine to euthanize animals. It is a Schedule II controlled substance in the United States, meaning it has a high potential for abuse and addiction.
Pentobarbital is available in both generic and brand-name forms. It is typically administered orally, intravenously, or intramuscularly. Common side effects include drowsiness, dizziness, and confusion. Long-term use of pentobarbital can lead to physical and psychological dependence.
Some companies that produce pentobarbital include Mylan Pharmaceuticals, Teva Pharmaceuticals, and Sandoz. Show Less Read more